Detection of Minimal Residual Disease by Flow Cytometry for Patients with Multiple Myeloma Submitted to Autologous Hematopoietic Stem Cell Transplantation

The treatment strategy in multiple myeloma (MM) is to get complete remission followed by high-dose chemotherapy and autologous Hematopoietic Stem Cell Transplantation (HSCT). Neoplastic Plasma Cells (NPCs) are CD45(−/dim), CD38(+high), CD138(+), CD19(−), and  CD56(+high) in most cases. The descripti...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Dal Bó, Suzane, Pezzi, Annelise, Amorin, Bruna, Valim, Vanessa, Isabel Bittencourt, Rosane, Silla, Lucia
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2013
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3705753/
https://ncbi.nlm.nih.gov/pubmed/23864957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/847672
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items